Stock Forecast

  AIkido Pharma Inc. ( AIKI) Stock. Should you Buy or Sell?    $ 5.88

0.02 (0.34 %)



AIkido Pharma Inc. Analysis

Updated on 10-09-2022
Symbol AIKI
Price $5.88
Beta 1.375
Volume Avg. $57.96 thousand
Market Cap $30.85 M
52 Week Range $4.3 - $16.66


AIkido Pharma Inc. opened the day at $5.88 which is +'0.34 % on yesterday's close. AIkido Pharma Inc. has a 52 week high of $16.66 and 52 week low of $4.3, which is a difference of $12.36. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $30.85 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy AIkido Pharma Inc. for $30.85 M, it would take 15 years to get your money back. AIkido Pharma Inc. are in the Biotechnology space which will have a sweet spot and industry standard for net profit multiples.



Price Chart


1 D | All


Financials




AIkido Pharma Inc. Stock Forecast - Is AIkido Pharma Inc. a Buy or Sell?


DCF ScoreStrong Buy
ROE ScoreNeutral
ROA ScoreNeutral
DE ScoreNeutral
PE ScoreSell
PB ScoreNeutral
Overall RecommendationNeutral

Growth and Value


PE Ratio -2.949
Dividend Yiel 0.000
Net Profit Margin 0.000


Valuing AIkido Pharma Inc.


Price Book Value Ratio 0.353 Price To Book Ratio 0.353
Price To Sales Ratio 0.000 Price Earnings Ratio -2.949


How liquid is AIkido Pharma Inc.


Current Ratio 74.262
Quick Ratio 68.967


Debt


Debt Ratio 0.009 Debt Equity Ratio 0.009
Long Term Debt To Capitalization 0.000 Total Debt To Capitalization 0.000



Latest news about AIkido Pharma Inc.


Why Is AIkido Pharma (AIKI) Stock Up 1,400%?

AIkido Pharma (AIKI) stock is skyrocketing on Tuesday but it's not due to any positive news from the biotechnology company. The post Why Is AIkido Pharma (AIKI) Stock Up 1,400%?

Date : 07/06/2022

Aikido Pharma (AIKI) Stock Price: 1-For-17 Reverse Split Goes Into Effect

A 1 for 17 reverse stock split of AIkido Pharma, Inc. (NASDAQ: AIKI) has gone into effect. These are the details.

Date : 07/06/2022

Trending Penny Stocks to Watch After Holiday Season

Which penny stocks are you watching right now? The post Trending Penny Stocks to Watch After Holiday Season appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Date : 02/01/2022

5 Top Penny Stocks To Watch Under $1 After CSCW Stock Explodes

There are so many traders looking for the best penny stocks 2021… The post 5 Top Penny Stocks To Watch Under $1 After CSCW Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Date : 01/11/2021

Best Penny Stocks to Buy Right Now? 3 to Watch This Month

If you're making a penny stocks watchlist in November, here's three you should check out The post Best Penny Stocks to Buy Right Now? 3 to Watch This Month appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Date : 01/11/2021





About AIkido Pharma Inc.


CEO : Mr. Anthony C. Hayes Esq.
Sector : Healthcare
Industry : Biotechnology

Website : https://www.aikidopharma.com

Exchange : NASDAQ Capital Market

Description :

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.


My Newsletter

Sign Up For Updates & Newsletters